Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Onal

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Critical Reviews in Oncology/Hematology|March 2, 2019
Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019Yazid Belkacemi, Terence T Sio, Laurianne Colson-Durand, et al.
Clinical Lung Cancer|September 2, 2025
Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung CancerRebecca A Deek, Jongmyung Kim, Ritesh Kumar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 1, 2020
Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002)Melis Gultekin, Caglayan Selenge Beduk Esen, Beril Balci, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 30, 2020
Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical stagingMelis Gultekin, Ozan Cem Guler, Sezin Yuce Sari, et al.
Translational Cancer Research|December 19, 2024
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancerTheodore Wang, Jongmyung Kim, Ritesh Kumar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 4, 2020
Treatment outcomes of metastasis-directed treatment using <sup>68</sup>Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)Pervin Hurmuz, Cem Onal, Gokhan Ozyigit, et al.
Clinical and Translational Radiation Oncology|June 23, 2021
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG surveyEnrica Seravalli, Petra S Kroon, John M Buatti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2018
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experienceBanu Atalar, Mahmut Ozsahin, Jason Call, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomicsYufeng Cao, Philip Sutera, William Silva Mendes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 23, 2025
Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 studyCaglayan Selenge Beduk Esen, Aysenur Elmali, Birhan Demirhan, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Critical Reviews in Oncology/Hematology|March 2, 2019
Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019Yazid Belkacemi, Terence T Sio, Laurianne Colson-Durand, et al.
Clinical Lung Cancer|September 2, 2025
Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung CancerRebecca A Deek, Jongmyung Kim, Ritesh Kumar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 1, 2020
Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002)Melis Gultekin, Caglayan Selenge Beduk Esen, Beril Balci, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 30, 2020
Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical stagingMelis Gultekin, Ozan Cem Guler, Sezin Yuce Sari, et al.
Translational Cancer Research|December 19, 2024
Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancerTheodore Wang, Jongmyung Kim, Ritesh Kumar, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 4, 2020
Treatment outcomes of metastasis-directed treatment using <sup>68</sup>Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)Pervin Hurmuz, Cem Onal, Gokhan Ozyigit, et al.
Clinical and Translational Radiation Oncology|June 23, 2021
The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG surveyEnrica Seravalli, Petra S Kroon, John M Buatti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2018
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experienceBanu Atalar, Mahmut Ozsahin, Jason Call, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomicsYufeng Cao, Philip Sutera, William Silva Mendes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 23, 2025
Long term outcomes of prostate cancer patients aged 55 years or younger treated with definitive radiotherapy: Trod 09-005 studyCaglayan Selenge Beduk Esen, Aysenur Elmali, Birhan Demirhan, et al.
Pageof 15